image
Coherus BioSciences, Inc. CHRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.744
-3.7 %
$ 85.7 M
Market Cap
-8.27
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 21.89% 27.17% 20.90%
Annual Report FY 10-K 2022-12-31 -35.37% -6.63% 2.64%
Annual Report FY 10-K 2021-12-31 -31.37% -231.63% -168.79%
Annual Report FY 10-K 2020-12-31 33.63% 47.21% 45.05%
Annual Report FY 10-K 2019-12-31 22783.74% 142.91% 152.72%
Annual Report FY 10-K 2018-12-31 0.00% 12.11% 11.94%
Annual Report FY 10-K 2017-12-31 -99.18% -87.04% -100.24%
Annual Report FY 10-K 2016-12-31 532.82% 42.96% 47.08%
Annual Report FY 10-K 2015-12-31 -3.42% -156.23% -238.68%
Annual Report FY 10-K 2014-12-31 1030.72% -62.46% -79.71%
Annual Report FY 10-K 2013-12-31 44.87% -62.44% 6.56%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 -5.09% 72.88% 80.04%
Quarterly Report Q2 8-K 2024-06-30 10.67% 69.86% 40.63%
Quarterly Report Q1 8-K 2024-03-31 137.58% 237.57% 47.27%
Quarterly Report Q4 8-K 2023-12-31 101.81% -20.24% -32.76%
Quarterly Report Q3 8-K 2023-09-30 64.16% 57.31% 60.22%
Quarterly Report Q2 8-K 2023-06-30 -2.39% 23.84% 21.52%
Quarterly Report Q1 8-K 2023-03-31 -46.04% 32.78% 16.29%
Quarterly Report Q4 8-K 2022-12-31 -38.19% -44.88% -30.21%
Quarterly Report Q3 8-K 2022-09-30 -44.94% -141.00% -145.37%
Quarterly Report Q2 8-K 2022-06-30 -31.37% -88.25% -82.14%
Quarterly Report Q1 8-K 2022-03-31 -27.60% 35.68% 51.65%
Quarterly Report Q4 8-K 2021-12-31 -33.55% -471.00% -240.77%
Quarterly Report Q3 8-K 2021-09-30 -27.34% -137.93% -97.24%
Quarterly Report Q2 8-K 2021-06-30 -35.40% -50.65% -37.00%
Quarterly Report Q1 8-K 2021-03-31 -28.53% -486.19% -409.51%
Quarterly Report Q4 8-K 2020-12-31 -10.85% -75.25% -63.53%
Quarterly Report Q3 8-K 2020-09-30 1.67% -40.62% -34.96%
Quarterly Report Q2 8-K 2020-06-30 62.61% 150.48% 137.55%
Quarterly Report Q1 8-K 2020-03-31 213.17% 277.82% 346.21%
Quarterly Report Q4 8-K 2019-12-31 0.00% 162.67% 174.43%
Quarterly Report Q3 8-K 2019-09-30 0.00% 179.99% 190.99%
Quarterly Report Q2 8-K 2019-06-30 0.00% 154.01% 161.22%
Quarterly Report Q1 8-K 2019-03-31 0.00% 54.84% 60.51%
Quarterly Report Q4 8-K 2018-12-31 0.00% -27.57% -30.21%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.31% -0.63%
Quarterly Report Q2 8-K 2018-06-30 0.00% 21.14% 20.71%
Quarterly Report Q1 8-K 2018-03-31 0.00% 40.76% 41.96%
Quarterly Report Q4 8-K 2017-12-31 0.00% 35.37% 36.75%
Quarterly Report Q3 8-K 2017-09-30 0.00% -70.28% -66.91%
Quarterly Report Q2 8-K 2017-06-30 -90.08% 20.91% 9.72%
Quarterly Report Q1 8-K 2017-03-31 -98.70% -14.36% -12.53%
Quarterly Report Q4 8-K 2016-12-31 -91.72% -44.91% -40.71%
Quarterly Report Q3 8-K 2016-09-30 2172.01% 217.67% 218.82%
Quarterly Report Q2 8-K 2016-06-30 104.89% -18.97% -6.52%
Quarterly Report Q1 8-K 2016-03-31 112.72% -60.56% -75.12%
Quarterly Report Q4 8-K 2015-12-31 57.06% -79.83% -96.56%
Quarterly Report Q3 8-K 2015-09-30 -55.35% -806.17% -1008.78%
Quarterly Report Q2 8-K 2015-06-30 38.29% -135.65% -228.33%
Quarterly Report Q1 8-K 2015-03-31 61.57% -61.80% -167.04%
Quarterly Report Q4 8-K 2014-12-31 427.03% -99.67% -153.27%
Quarterly Report Q3 8-K 2014-09-30 3072.33% 63.34% 5.31%
Quarterly Report Q2 8-K 2014-06-30 879.29% -186.57% -93.21%
Quarterly Report Q1 8-K 2014-03-31 610.67% -184.02% -45.79%
Quarterly Report Q4 8-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2013-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%